Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Animal Nutrition and Metabolism

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1641809

This article is part of the Research TopicExploring the Nexus: Diet and Microbiome Dynamics Across Gut, Oral, and Skin of Companion AnimalsView all 10 articles

Metabolic Profiling of Prebiotic, Probiotic, and Synbiotic Supplements in a Canine Colonic Fermentation Model: A Pilot Feasibility Study Reveals Distinct and Complementary Effects

Provisionally accepted
  • 1University of Teramo, Teramo, Italy
  • 2Indipendent researcher, Savona, Italy
  • 3Azienda Usl, Teramo, Italy

The final, formatted version of the article will be published soon.

The gut microbiota is a central player in canine health, influencing digestion, immune modulation, and metabolic homeostasis. Microbiota imbalance fuels interest in dietary interventions such as prebiotics, probiotics, and synbiotics (a combination of prebiotics and probiotics). This pilot feasibility study employed the SCIME™, a novel in vitro fermentation model simulating the canine colonic environment, to evaluate the metabolic effects of three dietary supplements using fecal inoculum from a single healthy canine donor. Products tested were Microbiotal (product M), a probiotic (product P, Lactobacilli reuteri), and a synbiotic (product M+P: Microbiotal +L. reuteri). Over a 2-week treatment period, fermentation parameters, including short-chain fatty acid (SCFA) production, acidification trends, and proteolytic activity, were measured using a high-resolution metabolomic profiling via the Laser-Assisted Rapid Evaporative Ionization Mass Spectrometry (LA-REIMS). Descriptive observations revealed distinct and complementary metabolic patterns. Microbiotal supplementation enhanced acidification in both the proximal and distal colon, with stimulation of acetate production in the proximal colon. Treatment with L. reuteri stimulated lactate production while reducing acetate and propionate levels. The synbiotic treatment showed combined effects, increasing acetate in the distal colon and producing metabolic shifts, as determined by LA-REIMS analysis. All treatments showed trends toward increased proteolytic markers in the distal colon. This pilot in vitro feasibility study demonstrates that prebiotics, probiotics, and synbiotics produce distinct metabolic fingerprints in vitro, warranting future validation through studies with multiple donors, independent SCIME™ runs, and in vivo trials to assess generalizability and explore potential applications in canine gastrointestinal research.

Keywords: Canine gut microbiota, prebiotic, probiotic, Metabolomics, colonic fermentation model, pilotfeasibility study

Received: 16 Jul 2025; Accepted: 16 Oct 2025.

Copyright: © 2025 GRAMENZI, Clerico, Bela', Leonardo, Fusaro and Pignataro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Giulia Pignataro, gpignataro@unite.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.